| Literature DB >> 35404484 |
Francesco Romano1, Claude Bailat2, Patrik Gonçalves Jorge2,3,4, Michael Lloyd Franz Lerch5, Arash Darafsheh6.
Abstract
The clinical translation of FLASH radiotherapy (RT) requires challenges related to dosimetry and beam monitoring of ultra-high dose rate (UHDR) beams to be addressed. Detectors currently in use suffer from saturation effects under UHDR regimes, requiring the introduction of correction factors. There is significant interest from the scientific community to identify the most reliable solutions and suitable experimental approaches for UHDR dosimetry. This interest is manifested through the increasing number of national and international projects recently proposed concerning UHDR dosimetry. Attaining the desired solutions and approaches requires further optimization of already established technologies as well as the investigation of novel radiation detection and dosimetry methods. New knowledge will also emerge to fill the gap in terms of validated protocols, assessing new dosimetric procedures and standardized methods. In this paper, we discuss the main challenges coming from the peculiar beam parameters characterizing UHDR beams for FLASH RT. These challenges vary considerably depending on the accelerator type and technique used to produce the relevant UHDR radiation environment. We also introduce some general considerations on how the different time structure in the production of the radiation beams, as well as the dose and dose-rate per pulse, can affect the detector response. Finally, we discuss the requirements that must characterize any proposed dosimeters for use in UDHR radiation environments. A detailed status of the current technology is provided, with the aim of discussing the detector features and their performance characteristics and/or limitations in UHDR regimes. We report on further developments for established detectors and novel approaches currently under investigation with a view to predict future directions in terms of dosimetry approaches, practical procedures, and protocols. Due to several on-going detector and dosimetry developments associated with UHDR radiation environment for FLASH RT it is not possible to provide a simple list of recommendations for the most suitable detectors for FLASH RT dosimetry. However, this article does provide the reader with a detailed description of the most up-to-date dosimetric approaches, and describes the behavior of the detectors operated under UHDR irradiation conditions and offers expert discussion on the current challenges which we believe are important and still need to be addressed in the clinical translation of FLASH RT.Entities:
Keywords: FLASH; dosimetry; proton therapy; radiotherapy; ultra-high dose rate
Mesh:
Year: 2022 PMID: 35404484 PMCID: PMC9544810 DOI: 10.1002/mp.15649
Source DB: PubMed Journal: Med Phys ISSN: 0094-2405 Impact factor: 4.506
Realization of FLASH radiation beams in recent literature (adapted with addition from Ref. )
| Year | Radiation type | Machine | Energy (MeV) | Average dose rate (Gy/s) | Dose per pulse (Gy/pulse) | Pulse repetition rate (Hz) | Field size | Purpose | Dosimetry method |
|---|---|---|---|---|---|---|---|---|---|
| 1995 | Photon | Brookhaven National Laboratory (USA) | 0.08 mean | 310–620 | Not provided | 52 MHz |
4 × 0.02/0.04 mm 0.075/0.2 × 7 mm | Rat neuro‐study | IC, RCF, TLD |
| 2014 | Electron | Kinetron Linac | 4.5 | 60 | 5 × 106 | 19 |
Ø 1.2 cm 1.8 cm × 2.0 cm | Mouse study (bilateral thorax irradiation) | Chemical dosimetry with blue methyl viologen |
| 2017 | Electron | Oriatron 6e Linac (Switzerland) | 6 | 100 | 5 × 106 | 100 | Ø 1.7 cm | Mouse study (brain irradiation) | TLD |
| 2017 | Electron | Varian 21EX (USA) | 9 and 20 | 35–210 | 1.7 × 106 | 182 | 1–5 cm @ 90% | Feasibility study | EBT2 RCF |
| 2018 | Photon | European Synchrotron Radiation Facility (France) | 0.102 mean | 37 | 1.2 × 104 Gy/s instantaneous | Continuous | 2 × 2 cm (reference size) | Mouse study (brain irradiation) | IC |
| 2018 | Proton | IBA isochronous cyclotron (France) | 138–198 | 40 | N/A | 106.14 MHz (quasi‐continuous) | ∼1.2 cm @ 90% | Feasibility study | Cylindrical IC, EBT3 RCF |
| 2019 | Electron | ELEKTA Precise Linac (Sweden) | 8 | 30–300 | Not provided | 200 | Ø 2 cm (at the highest dose rate) | Feasibility study | EBT3 RCF |
| 2019 | Electron | Kinetron Linac and Oriatron 6e (Switzerland) | 4.5 and 6 | 300 | 5 × 106 | Not provided | Ø 2.6 cm or 1.8–4.5 cm rectangular | Mini‐pig (skin) and cat (nasal tumor) study | TLD, alanine pellets, EBT3 RCF |
| 2019 | Electron | Oriatron ERT6 Linac (Switzerland) | 5.6 | 150 | 1 × 106 | 100 |
Ø 3.5 cm 1.3 depth @ 90% | Human patient treatment (skin) | Alanine pellets, EBT3 RCF |
| 2019 | Proton | Varian isochronous cyclotron (USA) | 245 | 40 | N/A | Quasi‐continuous | 1 cm × 3 cm | Mouse study (whole thorax irradiation) | Not provided |
| 2020 | Proton | IBA isochronous cyclotron (USA) | 230 | 80 | N/A | 106.14 MHz (quasi‐continuous) | ∼2 cm FWHM | Mouse study (abdomen irradiation) | Plane‐parallel IC |
| 2020 | Proton | Mevion synchrocyclotron (USA) | 70 | 100–200 | 0.16–0.32 Gy/pulse (8–16 × 103 Gy/s instantaneous) | 648 | ∼1.2 cm FWHM (5 mm @ 90% isodose) | Feasibility study | Plane‐parallel IC, FC, MC simulation, and RCF |
| 2020 | Proton | IBA isochronous cyclotron (USA) | 227.5 | 130 | N/A | 106 MHz (quasi‐continuous) | 1.6 × 1.2 cm2 ellipse | Mouse (partial abdomen irradiation) | Plane‐parallel IC, FC, MC simulation, EBT3 RCF |
| 2020 | Photon | ANSTO Australian Synchrotron | 0.07 and 0.09 mean | 40–350 (at treatment depth and filtration) | 200 (at 20 mm reference depth and filtration) | Continuous | 2 × 2 cm (reference dosimetry size) | Rat study (brain cancer irradiation) | Pinpoint IC (reference), silicon semiconductor, and MC |
| 2021 | Proton | Mevion synchrocyclotron (USA) | 60 | 120–160 | 0.22 Gy/pulse (9.3 × 103 Gy/s instantaneous) | 750 | Ø 1.1 cm FWHM (5 mm @ 90% isodose) | Feasibility of SOBP beam using a synchrocyclotron | IC, FC, MC simulation, and EBT‐XD RCF |
| 2021 | Electron | Varian Clinac 2100 C/D (USA) | 10 | 240–260 | 0.81 Gy/pulse | 360 | Ø 1–1.5 cm | Feasibility of UHDR at the machine's isocenter | EBT‐XD RCF |
| 2021 | Proton | Research isochronous cyclotron (Germany) | 68 | 75 | N/A | 20 MHz | Ø 1.3 cm | Preclinical setup for mouse irradiation | IC and RC |
| 2021 | Proton | COMET | 170—250 | 9000 (for a single spot) | N/A | 72.85 MHz | ∼2.3–5 mm (16 × 1.2 cm2 by scanning) | Feasibility study | FC |
| 2021 | Helium ion |
Synchrotron (Germany) | 145.74 MeV/u | 185 | N/A | Quasi‐continuous | 1 cm2 (by spot scanning) | In vitro study of dose, LET, and O2 concentration | Parallel‐plate IC |
| 2021 | Carbon ion | Synchrotron (Germany) | 280 MeV/u | 70 | N/A | Quasi‐continuous | 1 cm2 (by spot scanning) | Dosimetry and in vitro study | IC and EBT3 RCF |
Abbreviations: FC, Faraday cup; FWHM, full‐width at half‐maximum; IC, ion chamber; LET, linear energy transfer; MC, Monte Carlo; RCF, radiochromic film; TLD, thermoluminescent dosimeters; UHDR, ultra‐high dose rate.
FIGURE 1(a–f) Beam time structure and pulse duration (τ) for various accelerators delivering ultra‐high dose rate (UHDR) beams. Adapted with addition from Ref. 24
Characteristics of different types of dosimeters
| Dosimeter | Real time | In vivo dosimetry | Absolute/reference dosimetry | Beam monitoring | Spatial resolution | Temporal resolution | 2D dosimetry | Accuracy at conventional dose rates | Other considerations |
|---|---|---|---|---|---|---|---|---|---|
| Ion chamber | Yes | No | Yes | Yes | Several mm | 10–200 µs | Array | 1%–2% | Significant ion recombination at UHDRs |
| Semiconductor | Yes | Yes | No | Yes | Sub‐mm (or µm) | 1–10 ns | Yes | 2%–5% | Angular dependency, radiation damage, LET dependence |
| TLD | No | Yes | Yes | No | Several mm | N/A | No | 3%–10% | Energy dependence, time consuming, LET dependence |
| OSLD | No | Yes | Yes | No | Sub‐mm to mm | N/A | Array | 3%–5% | Energy dependence, quenching in high LET fields |
| Scintillator | Yes | Yes | Potentially | Potentially | Sub‐mm to mm | ns to µs | Array and sheet | 3%–5% | Quenching in high LET fields, Cherenkov radiation |
| Gas scintillator | Yes | No | No | Yes | Sub‐mm | N/A | Yes | 1% | Beam centroid measurement |
| Calorimeter | Yes | No | Yes | No | cm to several mm | ms–10 ms | No | <1% at the primary standard level |
Bulky, not easy to use, correction factors, time consuming |
| Film | No | Yes | Potentially | No | Tens of µm | N/A | Yes | 3%–5% | Quenching in high LET fields |
| Fricke | No | No | Yes | No | cm to sub‐mm | N/A | Potentially | <1% at primary standard level | Time consuming, complexity |
| Faraday cup | Yes (for charge measurements) | No | Yes | No | N/A | <µs | No | 2%–5% for commercial devices; 1%–2% for dedicated equipment | Measures the total collected charge (other detectors are required for dose determination) |
| Nuclear track detector | No | Yes | No | No | mm; sub‐mm with specialized equipment | N/A | Yes | 5%–7% | Time consuming, energy dependence, LET dependence |
| Alanine | No | Yes | Yes | No | mm | N/A | No | 2%–7% for doses larger than 10 Gy | Decreased accuracy for doses less than 10 Gy (minimum 2 Gy) |
| Integrated current transformer | Yes | Potentially | No | Yes | N/A | sub‐µs | No | <1% for charge measurements | Lack of 2D measurements, only charge measurements |
Abbreviations: LET, linear energy transfer; OSLD, optically stimulated luminescence dosimeter; TLD, thermoluminescent dosimeter; UHDR, ultra‐high dose rate.
Only accuracy for conventional dose rates has been indicated, as systematic studies for UHDR beams are still on‐going and final uncertainty budget for them is not yet fully established.
Some investigations have been done on real‐time film dosimetry.
Main source of uncertainty coming from effective area and energy spectrum measurements, required for the dose determination, as described in Section 3.5.
FIGURE 2(a–e) Ion recombination correction factors calculated for different chambers for the spread‐out Bragg peak (SOBP) beam. Circle and square symbols were calculated using Equation (4), triangle symbols were calculated using Equation (5), and star symbols were calculated using Equation (6). V H/V L = 2 in the legend indicates that Equation (5) was used with (‐400, ‐200) voltage pair for the Advanced Markus chamber. V H/V L = 3 in the legend indicates that Equation (5) was used with (‐450, ‐150) voltage pair. (f) Polarity correction factor for four different chambers irradiated by a proton beam, at 2–150 Gy/s dose rate, generated by a synchrocyclotron
FIGURE 3Dose–response curves obtained from the red channel of the EBT3 films irradiated by 198 MeV proton beams at 40 Gy/s and 5 Gy/s dose rates. Error bars are within the symbol size and the dashed curves represent 1‐sigma confidence level
FIGURE 4The optically stimulated luminescence dosimeters (OSLDs) dose measurement relative to the nominal dose as a function of the dose rate for the three setups studied by Christensen et al. The number of aggregated data points for each dose rate is given above each marker. The appearance of an under‐response above 1000 Gy/s is due to signal averaging of the narrow pencil beam over the OSLDs and is not manifestation of a dose‐rate dependency